Ann: Mayne Pharma announces sale of Metrics Contract Services, page-109

Well have a look at the thing in a whole: most of us are clearly disappointed the sale because this is the Best performing and growing part of the business for the company, many will question what is "left over" after this business is gone.

But we also need to look at the other side of the story: Metrics was acquired 10 years ago from US$120 and today's offer on the table is well over US$475m, that's nearly 300% return! time to profit-taking from company's point of view, when the potential of that business is reaching the peak.
I quite agree with Frank's comments "unlock the value", MYX has been a poor performer in recent years with sliding share price, any good assets or value such as Metrics, are actually "wrapped" in the bad sentiments and media coverage. So the sale of it crystalized the $$ and put it back into company's balance sheet, or return to share holders, from this prospective I think it's a good deal.

But anyway that's just my opinions, eventually market decides all.